Publication
HHS delegates exclusion authority to CMS
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
Global | Publication | May 20, 2026
In response to sanctions and export controls used by the United States and its allies, China has continued to strengthen its counter-sanctions regime, forming a legal framework centered on national security law, the PRC Anti-Foreign Sanctions Law (AFSL) and other regulations.2 The State Council further strengthened the framework in April 2026, as it promulgated two significant regulations:
China’s counter-sanctions regime is moving towards an enforcement and judicial application phase.
Against this backdrop, companies conducting supply chain due diligence or managing cross-border investigations, litigation, arbitration, and compliance matters involving China may face an increasingly complex and potentially conflicting regulatory environment. This article examines the key features of the Regulations and practical compliance considerations.
A. Supply Chain Security Provisions (Order No. 834)
The Supply Chain Security Provisions is China’s first administrative regulation specifically addressing industrial and supply chain security. The regulation aims to prevent industrial and supply chain security risks, enhance supply chain resilience, and safeguard economic and social stability as well as national security in China.
Order No. 834 has three key elements:
1. List of critical sectors
The Order directs Relevant State Council departments to publish a list of critical sectors for economic and social stability and national security, focusing on ensuring the stable production and circulation of raw materials, technologies, equipment, and products.
The scope extends beyond end products to upstream raw materials, intermediate technological links, and manufacturing equipment, reflecting a full-chain security approach. Although the specific lists have not yet been released, current policy trends suggest that sectors such as semiconductors, advanced manufacturing, energy, pharmaceuticals, and critical minerals are likely to be included.
2. Restrictions on Supply Chain-Related Investigations and Information Collection
Article 13 provides that
Where any organization or individual, in violation of China's laws, administrative regulations, and departmental rules and relevant provisions issued by the state, conducts investigations or other information collection activities related to industrial and supply chains within the territory of China, the relevant departments shall take corresponding disposition measures in accordance with law.
This appears to be a direct response to the impact of foreign supply chain regulatory regimes, including the U.S. Uyghur Forced Labor Prevention Act (UFLPA), Germany’s Supply Chain Due Diligence Act, and the EU Corporate Sustainability Due Diligence Directive (CSDDD). Against this backdrop, Article 13 may materially increase the risks of legal conflicts for companies engaging in supply chain investigations in China.
Article 13 does not appear to impose a blanket prohibition on all supply chain-related investigations. Rather, it prohibits information collection activities that violate applicable Chinese laws and regulations. The key issue is not the information collection activity itself, but whether the purpose, scope, methods, and cross-border data transfer arrangements comply with applicable PRC legal requirements.
3. Countermeasures Relating to Supply Chain Security
At the foreign state level, where a foreign country, region, or international organization violates international law or adopts discriminatory restrictive measures harming China’s supply chain security, China may impose measures including import/export restrictions, special charges, and inclusion on countermeasure lists.
At the foreign entity or individual level, any foreign commercial entities that, cease normal transactions with Chinese entities in violation of normal market transaction principles, or adopt discriminatory measures causing substantial harm to or threatening to cause substantial harm to China’s industrial or supply chain security, may face restrictions relating to import/export activities, investment, commercial cooperation, and entry into China.
These countermeasures may extend to entire corporate groups, not just the subsidiary. The regulation does not provide a specific equity threshold.
At the domestic entity level, the regulation requires organizations and individuals within China to implement relevant countermeasures. Violations may result in orders for rectification and restrictions on government procurement, bidding, import/export activities, and data transfers.
B. Regulation on Countering the Inappropriate Extraterritorial Jurisdiction of Foreign Countries (Order No. 835)
Order No. 835 addresses another central issue: how to respond when the inappropriate extraterritorial application of foreign laws adversely affects the business operations or compliance decisions of entities within China. The regulation’s underlying framework aims to identify inappropriate extraterritorial jurisdiction measures, block their implementation, and impose countermeasures against entities that promote or implement them.
Order No. 835 introduces broader enforcement mechanisms:
1. Identification of “Inappropriate Extraterritorial Jurisdiction Measures” (Article 6)
The identification mechanism constitutes the foundational step in the operation of Order No. 835. A formal determination that a foreign measure qualifies as an “inappropriate extraterritorial jurisdiction measure” is a prerequisite to activating the subsequent blocking, countermeasure, and judicial remedy mechanisms.
Article 6 establishes a dual-track mechanism:
Measures deemed as inappropriate may be publicly announced.
2. Enforcement Prohibition Orders and Exemption Mechanism (Articles 13 & 6(4))
Order No. 835 establishes a tiered enforcement framework:
3. Malicious Entity List (Article 8)
The Malicious Entity List constitutes one of the key countermeasure mechanisms. It applies to foreign organizations and individuals that “promote or participate in the implementation” of inappropriate extraterritorial jurisdiction measures. The concept of “promotion or participation” appears intentionally broad and could potentially extend to conduct such as planning, coercion, financing, or facilitation.
Categories of countermeasures include visa and entry restrictions, asset freezes, prohibitions on data provision, restrictions on transactions, import/export, investments and fines.
China's countersanctions framework can reach further down a corporate chain because it requires only a factual determination of actual control or involvement in establishment and operations, not proof of majority ownership — leaving less room for insulation through ownership structures.
China currently maintains three principal list-based countermeasure regimes (excluding export control-related lists): the Countermeasures List under the AFSL, the Unreliable Entity List, and the Malicious Entity List under Order No. 835. These regimes differ in both scope and regulatory function and may operate in parallel. A single foreign entity could potentially be designated under multiple regimes based on different categories of conduct.
Relief Mechanisms for Listed Parties (Articles 9 and 11)
Parties listed on the Malicious Entity List may apply for suspension, modification, or removal of countermeasures by demonstrating rectification and remedial measures, though the regulation does not define standards, evidentiary thresholds or review timelines.
Listed parties may also apply to the Ministry of Justice for transaction-specific authorizations under special circumstances, specifying the justification, scope, and nature of the proposed activities.
4. Judicial Remedies (Article 14)
Article 14 provides that where any organization or individual implements or assists in implementing foreign inappropriate extraterritorial jurisdiction measures that infringe upon the lawful rights and interests of Chinese citizens or organizations, the affected party may bring a lawsuit before a Chinese court seeking cessation of infringement and compensation for losses.
This provision potentially provides Chinese companies with a direct litigation mechanism against counterparties. Foreign customers, suppliers, financial institutions, or business partners that implement or assist in implementing relevant foreign measures could face potential litigation exposure in China.
5. Coordination with the Blocking Rules (Article 19)
Order No. 835 and the Blocking Rules complement each other but address different scenarios. The Blocking Rules, administered primarily by MOFCOM, target foreign measures restricting Chinese entities from normal business with third-country parties, known as “secondary sanctions.”. Order No. 835, led by the Ministry of Justice, covers broader extraterritorial jurisdiction issues, including compulsory foreign information collection and discriminatory review mechanisms.
For multinational corporations, financial institutions, and professional services firms operating across jurisdictions, these Regulations introduce a heightened risk of regulatory infringement — particularly if compliance with one jurisdiction's requirements may trigger non-compliance in another.
Entities conducting supply chain due diligence, responding to foreign regulatory demands, or implementing sanctions-related restrictions should carefully assess their exposure under both Regulations, with particular attention to the breadth of the countermeasure mechanisms, the potential for group-wide liability, and the emerging judicial enforcement dimension. As China's countersanctions regime moves from legislative construction to active enforcement, a proactive and integrated approach to cross-border compliance — one that accounts for the legal requirements of all relevant jurisdictions simultaneously — will be essential to managing the increasingly complex risks of operating within competing regulatory regimes.
Publication
HHS Secretary Robert F. Kennedy Jr. announced that the CMS would exercise exclusion authority to remove “bad actors” from federal healthcare programs “effective immediately.”
Publication
Now in its seventh year, our annual English Premier League (EPL) football report, Keeping Possession, captures insights from our global sports law team on the key trends and topics shaping the landscape of English football.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2026